Coeptis Therapeutics Holdings, Inc. (COEP)
Apr 24, 2026 - COEP merged into ZSQR
16.40
+0.19 (1.17%)
Inactive · Last trade price
on Apr 24, 2026
COEP Employees
As of December 31, 2025, Coeptis Therapeutics Holdings had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$227,174
Profits / Employee
-$1,986,169
Market Cap
102.06M
Employees Chart
COEP News
- 4 days ago - Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market - PRNewsWire
- 21 days ago - Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing Application - GlobeNewsWire
- 2 months ago - Coeptis Receives Shareholder Approval Towards Z Squared Merger - GlobeNewsWire
- 4 months ago - Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared - GlobeNewsWire
- 7 months ago - Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating - GlobeNewsWire
- 10 months ago - Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd - GlobeNewsWire
- 10 months ago - Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared - GlobeNewsWire
- 11 months ago - Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology - GlobeNewsWire